(1) Background: The optimal timing of adjuvant chemotherapy (CT) in gastrointestinal
malignancies is still a matter of debate. For colorectal cancer, it is recommended to start post …

Importance Adjuvant chemotherapy offers a survival benefit to a number of staging
scenarios in non–small-cell lung cancer. Variable recovery from lung cancer surgery may …

Anemia is a common problem when patients present with cancer, and it can worsen during
treatment. Anemia can directly impact the cognitive and physical quality of life and may …

Background Postoperative adjuvant chemotherapy (AC) is now well-accepted as standard
for high-risk stage II and stage III colorectal cancer (CRC) patients, however the optimal time …

Background Adjuvant therapy for colorectal cancer (CRC) in patients aged≥ 75 years is
supported by inadequate evidence, although such patients are increasing in number …

Abstract Background Non-Hispanic black (NHB) adults with cancer may have longer time-to-
treatment than non-Hispanic whites (NHW) in the United States. Unequal access to medical …

Background To examine the impact of chemotherapy delay on survival in patients with stage
II or III colon cancer and the factors associated with the delay (≥ 8 weeks) of adjuvant …

Aim The objectives were to recognize the risk factors for surgical site infections (SSIs) after
surgery due to colorectal cancer and to assess the impact of mechanical bowel preparation …

Background. Surgical treatment is the cornerstone in the management of colorectal cancer
(CRC) liver metastases. The aim of this study is to identify clinicopathological factors …

Aim By understanding the reasons for delays in adjuvant chemotherapy (AC) after colonic
resection, there is the potential to improve patient outcome. The aim of this study is to …